In obesity and T2D, the depletion of beneficial taxa allows the expansion of potentially harmful, endotoxin-producing bacteria beyond physiological equilibrium (9092)
Last Published 10.01.2025 Effective Date: 10.01.2025 This policy addresses the use of white blood cell colony stimulating factors (CSFs), including the drug products Fulphila, Fylnetra, Granix, Leukine, Neulasta, Neupogen, Nivestym, Nyvepria, Releuko, Rolvedon, Stimufend, Udenyca, Zarxio, and Ziextenzo
Retatrutide is a novel multi-receptor targeted medication
Andrew Kraftson, a clinical associate professor at the University of Michigan Medical School, said that he had to stop a patient from continuing on the medications because the person wanted to keep losing weight, even when there was no clear medical benefit to doing so
Specific areas to address include protein intake, which becomes particularly important during rapid weight loss